Identification of Prognostic Factors Related to Super Enhancer-Regulated ceRNA Network in Metastatic Lung Adenocarcinoma

References

• Zhang H, Guo L, Chen J. Rationale for lung adenocarcinoma prevention and drug development based on molecular biology during carcinogenesis. Onco Targets Ther. 2020;13:3085–3091. doi:10.2147/OTT.S248436
   PubMed Web of Science ®Google Scholar
• Sacher AG, Dahlberg SE, Heng J, Mach S, Janne PA, Oxnard GR. Association between younger age and targetable genomic alterations and prognosis in non-small-cell lung cancer. JAMA Oncol. 2016;2(3):313–320. doi:10.1001/jamaoncol.2015.4482
   PubMed Web of Science ®Google Scholar
• Huang J, Pan B, Xia G, Zhu J, Li C, Feng J. LncRNA SNHG15 regulates EGFR-TKI acquired resistance in lung adenocarcinoma through sponging miR-451 to upregulate MDR-1. Cell Death Dis. 2020;11(7):525. doi:10.1038/s41419-020-2683-x
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34. doi:10.3322/caac.21551
   PubMed Web of Science ®Google Scholar
• Peng WX, Koirala P, Mo YY. LncRNA-mediated regulation of cell signaling in cancer. Oncogene. 2017;36(41):5661–5667. doi:10.1038/onc.2017.184
   PubMed Web of Science ®Google Scholar
• Sedano MJ, Harrison AL, Zilaie M, et al. Emerging roles of estrogen-regulated enhancer and long non-coding RNAs. Int J Mol Sci. 2020;21(10):3711. doi:10.3390/ijms21103711
   PubMed Web of Science ®Google Scholar
• Li J, Meng H, Bai Y, Wang K. Regulation of lncRNA and its role in cancer metastasis. Oncol Res. 2016;23(5):205–217. doi:10.3727/096504016X14549667334007
   PubMed Web of Science ®Google Scholar
• Manning AK, Goustin AS, Kleinbrink EL, et al. A long non-coding RNA, LOC157273, is an effector transcript at the chromosome 8p23.1-PPP1R3B metabolic traits and type 2 diabetes risk locus. Front Genet. 2020;11:615. doi:10.3389/fgene.2020.00615
   PubMed Web of Science ®Google Scholar
• Collins L, Binder P, Chen H, Wang X. Regulation of long non-coding RNAs and microRNAs in heart disease: insight into mechanisms and therapeutic approaches. Front Physiol. 2020;11:798. doi:10.3389/fphys.2020.00798
   PubMed Web of Science ®Google Scholar
• Zhao X, Li X, Zhou L, et al. LncRNA HOXA11-AS drives cisplatin resistance of human LUAD cells via modulating miR-454-3p/Stat3. Cancer Sci. 2018;109(10):3068–3079. doi:10.1111/cas.13764
   PubMed Web of Science ®Google Scholar
• Chen R, Xia W, Wang S, et al. Long noncoding RNA SBF2-AS1 is critical for tumorigenesis of early-stage lung adenocarcinoma. Mol Ther Nucleic Acids. 2019;16:543–553. doi:10.1016/j.omtn.2019.04.004
   PubMedGoogle Scholar
• Qi X, Zhang DH, Wu N, Xiao JH, Wang X, Ma W. ceRNA in cancer: possible functions and clinical implications. J Med Genet. 2015;52(10):710–718. doi:10.1136/jmedgenet-2015-103334
   PubMed Web of Science ®Google Scholar
• Liu X, Huang S, Guan Y, Zhang Q. Long noncoding RNA OSER1AS1 promotes the malignant properties of nonsmall cell lung cancer by sponging microRNA4333p and thereby increasing Smad2 expression. Oncol Rep. 2020;44(2):599–610. doi:10.3892/or.2020.7645
   PubMed Web of Science ®Google Scholar
• Liu C, Li X, Hao Y, et al. STAT1-induced upregulation of lncRNA KTN1-AS1 predicts poor prognosis and facilitates non-small cell lung cancer progression via miR-23b/DEPDC1 axis. Aging. 2020;12(9):8680–8701. doi:10.18632/aging.103191
   PubMedGoogle Scholar
• Fang C, Wang L, Gong C, Wu W, Yao C, Zhu S. Long non-coding RNAs: how to regulate the metastasis of non-small-cell lung cancer. J Cell Mol Med. 2020;24(6):3282–3291. doi:10.1111/jcmm.15054
   PubMed Web of Science ®Google Scholar
• Whyte WA, Orlando DA, Hnisz D, et al. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell. 2013;153(2):307–319. doi:10.1016/j.cell.2013.03.035
   PubMed Web of Science ®Google Scholar
• Li GH, Qu Q, Qi TT, et al. Super-enhancers: a new frontier for epigenetic modifiers in cancer chemoresistance. J Exp Clin Cancer Res. 2021;40(1):174. doi:10.1186/s13046-021-01974-y
   PubMed Web of Science ®Google Scholar
• Yang D, He Y, Wu B, et al. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma. Cancer Biomark. 2020;29(3):399–416. doi:10.3233/CBM-200133
   PubMed Web of Science ®Google Scholar
• Zhang X, Du L, Han J, et al. Novel long non-coding RNA LINC02323 promotes epithelial-mesenchymal transition and metastasis via sponging miR-1343-3p in lung adenocarcinoma. Thorac Cancer. 2020;11(9):2506–2516
   PubMed Web of Science ®Google Scholar
• Zhao M, Xin XF, Zhang JY, Dai W, Lv TF, Song Y. LncRNA GMDS-AS1 inhibits lung adenocarcinoma development by regulating miR-96-5p/CYLD signaling. Cancer Med. 2020;9(3):1196–1208. doi:10.1002/cam4.2776
   PubMed Web of Science ®Google Scholar
• Jia Y, Duan Y, Liu T, et al. LncRNA TTN-AS1 promotes migration, invasion, and epithelial mesenchymal transition of lung adenocarcinoma via sponging miR-142-5p to regulate CDK5. Cell Death Dis. 2019;10(8):573. doi:10.1038/s41419-019-1811-y
   PubMed Web of Science ®Google Scholar
• Thandapani P. Super-enhancers in cancer. Pharmacol Ther. 2019;199:129–138. doi:10.1016/j.pharmthera.2019.02.014
   PubMed Web of Science ®Google Scholar
• Sengupta S, George RE. Super-enhancer-driven transcriptional dependencies in cancer. Trends Cancer. 2017;3(4):269–281. doi:10.1016/j.trecan.2017.03.006
   PubMed Web of Science ®Google Scholar
• Kathagen-Buhmann A, Maire CL, Weller J, et al. The secreted glycolytic enzyme GPI/AMF stimulates glioblastoma cell migration and invasion in an autocrine fashion but can have anti-proliferative effects. Neuro Oncol. 2018;20(12):1594–1605. doi:10.1093/neuonc/noy117
   PubMed Web of Science ®Google Scholar
• Maniswami RR, Prashanth S, Karanth AV, et al. PLK4: a link between centriole biogenesis and cancer. Expert Opin Ther Targets. 2018;22(1):59–73. doi:10.1080/14728222.2018.1410140
   PubMed Web of Science ®Google Scholar
• Zhu Y, Liu Z, Qu Y, et al. YLZ-F5, a novel polo-like kinase 4 inhibitor, inhibits human ovarian cancer cell growth by inducing apoptosis and mitotic defects. Cancer Chemother Pharmacol. 2020;86(1):33–43. doi:10.1007/s00280-020-04098-w
   PubMed Web of Science ®Google Scholar
• Shinmura K, Kurabe N, Goto M, et al. PLK4 overexpression and its effect on centrosome regulation and chromosome stability in human gastric cancer. Mol Biol Rep. 2014;41(10):6635–6644. doi:10.1007/s11033-014-3546-2
   PubMed Web of Science ®Google Scholar
• Yu H, Zhang D, Li Z, Wang M. E2F transcription factor 8 promotes proliferation and radioresistance in glioblastoma. Pathol Res Pract. 2020;216(8):153030. doi:10.1016/j.prp.2020.153030
   PubMed Web of Science ®Google Scholar
• Yan Z, Zhang W, Xiong Y, Wang Y, Li Z. Long noncoding RNA FLVCR1-AS1 aggravates biological behaviors of glioma cells via targeting miR-4731-5p/E2F2 axis. Biochem Biophys Res Commun. 2020;521(3):716–720. doi:10.1016/j.bbrc.2019.10.106
   PubMed Web of Science ®Google Scholar
• Iwasaki T, Tanaka K, Kawano M, Itonaga I, Tsumura H. Tumor-suppressive microRNA-let-7a inhibits cell proliferation via targeting of E2F2 in osteosarcoma cells. Int J Oncol. 2015;46(4):1543–1550. doi:10.3892/ijo.2015.2867
   PubMed Web of Science ®Google Scholar
• Dou L, Han K, Xiao M, Lv F. miR-223-5p suppresses tumor growth and metastasis in non-small cell lung cancer by targeting E2F8. Oncol Res. 2019;27(2):261–268. doi:10.3727/096504018X15219188894056
   PubMed Web of Science ®Google Scholar
• Misono S, Seki N, Mizuno K, et al. Dual strands of the miR-145 duplex (miR-145-5p and miR-145-3p) regulate oncogenes in lung adenocarcinoma pathogenesis. J Hum Genet. 2018;63(10):1015–1028. doi:10.1038/s10038-018-0497-9
   PubMed Web of Science ®Google Scholar
• Tong J, Shen Y, Chen X, et al. FKBP3 mediates oxaliplatin resistance in colorectal cancer cells by regulating HDAC2 expression. Oncol Rep. 2019. doi:10.3892/or.2019.7259
   Web of Science ®Google Scholar
• Gdynia G, Lehmann-Koch J, Sieber S, et al. BLOC1S2 interacts with the HIPPI protein and sensitizes NCH89 glioblastoma cells to apoptosis. Apoptosis. 2008;13(3):437–447. doi:10.1007/s10495-007-0176-3
   PubMed Web of Science ®Google Scholar
• Fu X, Mao X, Wang Y, Ding X, Li Y. Let-7c-5p inhibits cell proliferation and induces cell apoptosis by targeting ERCC6 in breast cancer. Oncol Rep. 2017;38(3):1851–1856. doi:10.3892/or.2017.5839
   PubMed Web of Science ®Google Scholar
• Ceccaldi R, Sarangi P, D’Andrea AD. The Fanconi anaemia pathway: new players and new functions. Nat Rev Mol Cell Biol. 2016;17(6):337–349. doi:10.1038/nrm.2016.48
   PubMed Web of Science ®Google Scholar
• Kolinjivadi AM, Crismani W, Ngeow J. Emerging functions of Fanconi anemia genes in replication fork protection pathways. Hum Mol Genet. 2020;29(R2):R158–R164. doi:10.1093/hmg/ddaa087
   PubMed Web of Science ®Google Scholar
• Roh YG, Mun JY, Kim SK, et al. Fanconi anemia pathway activation by FOXM1 is critical to bladder cancer recurrence and anticancer drug resistance. Cancers. 2020;12(6):1417. doi:10.3390/cancers12061417
   PubMed Web of Science ®Google Scholar
• Fang CB, Wu HT, Zhang ML, Liu J, Zhang GJ. Fanconi anemia pathway: mechanisms of breast cancer Predisposition development and potential therapeutic targets. Front Cell Dev Biol. 2020;8:160. doi:10.3389/fcell.2020.00160
   PubMed Web of Science ®Google Scholar